Texas Capital Bancshares Inc/Tx (TCBIO) Loans - Loss Allowance (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported Loans - Loss Allowance for 17 consecutive years, with $268.3 million the latest figure, recorded in Q2 2026.

• Quarterly Loans - Loss Allowance fell 3.38% year-over-year to $268.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $268.3 million (down 3.38% YoY) and the FY2025 annual result came in at $270.6 million, changed 0.42% from the prior year.
• Loans - Loss Allowance eased to $268.3 million in Q2 2026 per TCBIO's latest filing, from $270.4 million in the prior quarter.
• Over the last five years, Loans - Loss Allowance for TCBIO reached as high as $278.4 million in Q1 2025 and fell as low as $211.2 million in Q1 2022.
• A 5-year average of $257.6 million and a median of $265.6 million in 2024 frame the typical range for Loans - Loss Allowance.
• Annual changes were most pronounced in 2022 — Loans - Loss Allowance dropped 12.92% — and 2023, when it climbed 23.57%.
• Year by year, Loans - Loss Allowance stood at $253.5 million in 2022, then slipped by 1.38% to $250.0 million in 2023, then advanced by 8.7% to $271.7 million in 2024, then declined by 0.42% to $270.6 million in 2025, then decreased by 0.85% to $268.3 million in 2026.
• According to Business Quant data, Loans - Loss Allowance over the past three periods registered $268.3 million, $270.4 million, and $270.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.